Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

LISDEXANFETAMINA TEVA 30 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/LISDEXANFETAMINA TEVA 30 MG CAPSULAS DURAS EFG

Approved

STANDARD

LISDEXANFETAMINA TEVA 30 MG CAPSULAS DURAS EFG

Teva B.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Feb 14, 2023
Approval ID: a4ee759e618cb975
Company: Teva B.V.
Type: Standard

Approval Details

Approval Id: a4ee759e618cb975
Drug Cima Aemps Name: LISDEXANFETAMINA TEVA 30 MG CAPSULAS DURAS EFG
Register Number: 88634
Holder Company Name: Teva B.V.
Marketing Company Name: Teva Pharma S.L.U.
Holder Company Detail Path: /organization/teva-pharma-b-v
Authorization Date: 2023-02-14
Dosage Form: CÁPSULA DURA
Dose: 30 mg
Route Of Administration: VÍA ORAL
Prescription Type: Diagnóstico Hospitalario. Psicótropos
Commercialized: No
Company Name: Teva B.V.
Company Detail Path: /organization/teva-pharma-b-v

Company Information

Pharmaceutical Company Name: Teva Pharma B.V.
Country Name: Netherlands
City Name: haarlem,noord-holland,country_nl
Address: Swensweg 5
Website: http://www.tevapharm.com

Active Ingredients

LISDEXANFETAMINA DIMESILATO

30 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Feb 14, 2023

Approval ID

a4ee759e618cb975

Type

Standard

Back to CIMA-AEMPS Approvals